Urs Benck1,2, Peter Schnuelle3,4, Bernd Krüger3,4, Kai Nowak4,5, Thomas Riester4,5, Heiko Mundt3,4, Niklas Lutz3,4, Matthias Jung3,4, Rainer Birck3,4, Bernhard K Krämer6,7, Wilhelm H Schmitt3,4. 1. Vth Department of Medicine (Nephrology, Endocrinology, Rheumatology), Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. urs.benck@umm.de. 2. Medical Faculty Mannheim, Renal Transplant Center, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. urs.benck@umm.de. 3. Vth Department of Medicine (Nephrology, Endocrinology, Rheumatology), Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. 4. Medical Faculty Mannheim, Renal Transplant Center, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. 5. Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Mannheim, Germany. 6. Vth Department of Medicine (Nephrology, Endocrinology, Rheumatology), Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. bernhard.kraemer@umm.de. 7. Medical Faculty Mannheim, Renal Transplant Center, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. bernhard.kraemer@umm.de.
Abstract
BACKGROUND: Whether organs from donors after brain death (DBD) with acute kidney injury (AKI) should be accepted for transplantation is still a matter of debate. METHODS: This was a retrospective, center-based, matched cohort study of 33 renal transplant patients who received a renal allograft from a DBD with AKI. Sixty-five kidney transplants without donor AKI transplanted directly before and after the index transplantation served as controls. RESULTS: All AKI donors were classified according to RIFLE criteria: 9.1 % Risk, 54.6 % Injury, and 36.4 % Failure. Mean serum creatinine was 2.41 ± 0.88 mg/dL at procurement and 1.06 ± 0.32 mg/dL on admission. AKI donors had lower 24-h urine production (3.22 ± 1.95 vs. 4.59 ± 2.53 L, p = 0.009) and received more frequently noradrenaline (93.9 vs. 72.3 %, p = 0.02) and/or adrenaline (15.2 vs. 1.5 %, p = 0.02). Recipient and transplant characteristics were similar except a more favorable HLA match in control patients (p = 0.01). Hemodialysis posttransplant was more frequently used in AKI recipients (14/33 [42.4 %] vs. 18/65 [27.7 %], p = 0.17). While significant elevations in serum creatinine were noted in these patients until 10 days after transplantation, this difference lost statistical significance by day 14. One-year graft survival was very similar when comparing the groups (93.6 % [95 % CI 76.8-98.4 %] vs. 90.3 % [95 % CI 79.6-95.5 %], log rank p = 0.58). CONCLUSIONS: Kidneys from AKI donors can be transplanted with excellent intermediate prognosis and should not be discarded.
BACKGROUND: Whether organs from donors after brain death (DBD) with acute kidney injury (AKI) should be accepted for transplantation is still a matter of debate. METHODS: This was a retrospective, center-based, matched cohort study of 33 renal transplant patients who received a renal allograft from a DBD with AKI. Sixty-five kidney transplants without donor AKI transplanted directly before and after the index transplantation served as controls. RESULTS: All AKI donors were classified according to RIFLE criteria: 9.1 % Risk, 54.6 % Injury, and 36.4 % Failure. Mean serum creatinine was 2.41 ± 0.88 mg/dL at procurement and 1.06 ± 0.32 mg/dL on admission. AKI donors had lower 24-h urine production (3.22 ± 1.95 vs. 4.59 ± 2.53 L, p = 0.009) and received more frequently noradrenaline (93.9 vs. 72.3 %, p = 0.02) and/or adrenaline (15.2 vs. 1.5 %, p = 0.02). Recipient and transplant characteristics were similar except a more favorable HLA match in control patients (p = 0.01). Hemodialysis posttransplant was more frequently used in AKI recipients (14/33 [42.4 %] vs. 18/65 [27.7 %], p = 0.17). While significant elevations in serum creatinine were noted in these patients until 10 days after transplantation, this difference lost statistical significance by day 14. One-year graft survival was very similar when comparing the groups (93.6 % [95 % CI 76.8-98.4 %] vs. 90.3 % [95 % CI 79.6-95.5 %], log rank p = 0.58). CONCLUSIONS: Kidneys from AKI donors can be transplanted with excellent intermediate prognosis and should not be discarded.
Authors: Stuart M Greenstein; Norman Moore; Patricia McDonough; Richard Schechner; Vivian Tellis Journal: Clin Transplant Date: 2008-05-19 Impact factor: 2.863
Authors: Richard Ugarte; Edward Kraus; Robert A Montgomery; James F Burdick; Lloyd Ratner; Mark Haas; Alan M Hawxby; Seth J Karp Journal: Transplantation Date: 2005-09-27 Impact factor: 4.939
Authors: Benjamin Deroure; Nassim Kamar; Helene Depreneuf; Antoine Jacquet; Helene Francois; Bernard Charpentier; Lionel Rostaing; Antoine Durrbach Journal: Nephrol Dial Transplant Date: 2010-02-17 Impact factor: 5.992
Authors: I E Hall; B Schröppel; M D Doshi; J Ficek; F L Weng; R D Hasz; H Thiessen-Philbrook; P P Reese; C R Parikh Journal: Am J Transplant Date: 2015-03-11 Impact factor: 8.086
Authors: Alan C Farney; Jeffrey Rogers; Giuseppe Orlando; Samer al-Geizawi; Michael Buckley; Umar Farooq; Yousef al-Shraideh; Robert J Stratta Journal: J Am Coll Surg Date: 2013-02-06 Impact factor: 6.113
Authors: Isaac E Hall; Enver Akalin; Jonathan S Bromberg; Mona D Doshi; Tom Greene; Meera N Harhay; Yaqi Jia; Sherry G Mansour; Sumit Mohan; Thangamani Muthukumar; Peter P Reese; Bernd Schröppel; Pooja Singh; Heather R Thiessen-Philbrook; Francis L Weng; Chirag R Parikh Journal: Kidney Int Date: 2018-11-20 Impact factor: 10.612
Authors: Jana Bauer; Sascha Grzella; Malwina Bialobrzecka; Lea Berger; Timm H Westhoff; Richard Viebahn; Peter Schenker Journal: Ann Transplant Date: 2018-12-07 Impact factor: 1.530
Authors: Katharina Schütte-Nütgen; Markus Finke; Sabrina Ehlert; Gerold Thölking; Hermann Pavenstädt; Barbara Suwelack; Daniel Palmes; Ralf Bahde; Raphael Koch; Stefan Reuter Journal: PLoS One Date: 2019-03-13 Impact factor: 3.240
Authors: Carolina Victoria Cruz Junho; Laura González-Lafuente; José Alberto Navarro-García; Elena Rodríguez-Sánchez; Marcela Sorelli Carneiro-Ramos; Gema Ruiz-Hurtado Journal: Int J Mol Sci Date: 2022-02-18 Impact factor: 5.923
Authors: Neel Koyawala; Peter P Reese; Isaac E Hall; Yaqi Jia; Heather R Thiessen-Philbrook; Sherry G Mansour; Mona D Doshi; Enver Akalin; Jonathan S Bromberg; Meera N Harhay; Sumit Mohan; Thangamani Muthukumar; Bernd Schröppel; Pooja Singh; Francis L Weng; Chirag R Parikh Journal: Transplantation Date: 2020-06 Impact factor: 5.385